Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs MEDICAMEN BI - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. MEDICAMEN BI MARKSANS PHARMA./
MEDICAMEN BI
 
P/E (TTM) x 40.3 95.0 42.4% View Chart
P/BV x 6.8 2.6 255.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 MARKSANS PHARMA.   MEDICAMEN BI
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-24
MEDICAMEN BI
Mar-24
MARKSANS PHARMA./
MEDICAMEN BI
5-Yr Chart
Click to enlarge
High Rs179904 19.8%   
Low Rs70357 19.5%   
Sales per share (Unadj.) Rs48.0141.1 34.1%  
Earnings per share (Unadj.) Rs6.97.5 93.0%  
Cash flow per share (Unadj.) Rs8.613.1 65.8%  
Dividends per share (Unadj.) Rs0.600-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs45.6162.9 28.0%  
Shares outstanding (eoy) m453.1612.71 3,565.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.64.5 57.9%   
Avg P/E ratio x17.984.4 21.2%  
P/CF ratio (eoy) x14.548.3 30.0%  
Price / Book Value ratio x2.73.9 70.5%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m56,3338,012 703.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,936291 1,010.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m21,7741,793 1,214.4%  
Other income Rs m50423 2,167.8%   
Total revenues Rs m22,2781,816 1,226.6%   
Gross profit Rs m4,586235 1,950.1%  
Depreciation Rs m74371 1,047.1%   
Interest Rs m11257 197.5%   
Profit before tax Rs m4,235131 3,239.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,08636 3,032.7%   
Profit after tax Rs m3,14995 3,316.8%  
Gross profit margin %21.113.1 160.6%  
Effective tax rate %25.627.4 93.6%   
Net profit margin %14.55.3 273.1%  
BALANCE SHEET DATA
Current assets Rs m18,6251,596 1,167.0%   
Current liabilities Rs m3,898846 461.1%   
Net working cap to sales %67.641.8 161.6%  
Current ratio x4.81.9 253.1%  
Inventory Days Days1069 14.6%  
Debtors Days Days761,125 6.8%  
Net fixed assets Rs m8,1851,257 650.9%   
Share capital Rs m453127 356.4%   
"Free" reserves Rs m20,1971,943 1,039.7%   
Net worth Rs m20,6512,070 997.7%   
Long term debt Rs m013 0.0%   
Total assets Rs m26,8102,920 918.0%  
Interest coverage x38.83.3 1,174.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.6 132.3%   
Return on assets %12.25.2 234.2%  
Return on equity %15.24.6 332.4%  
Return on capital %21.19.0 233.8%  
Exports to sales %070.0 0.0%   
Imports to sales %6.97.1 97.4%   
Exports (fob) Rs mNA1,255 0.0%   
Imports (cif) Rs m1,511128 1,183.0%   
Fx inflow Rs m8,4661,255 674.7%   
Fx outflow Rs m1,511215 701.9%   
Net fx Rs m6,9541,039 669.1%   
CASH FLOW
From Operations Rs m2,304-67 -3,416.5%  
From Investments Rs m-1,408-56 2,531.7%  
From Financial Activity Rs m-68763 -1,088.5%  
Net Cashflow Rs m208-60 -347.7%  

Share Holding

Indian Promoters % 43.9 43.0 102.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.4 1.2 2,065.9%  
FIIs % 21.3 0.1 35,516.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.1 57.0 98.5%  
Shareholders   248,845 10,792 2,305.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on MARKSANS PHARMA. vs MEDICAMEN BI

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs MEDICAMEN BI Share Price Performance

Period MARKSANS PHARMA. MEDICAMEN BI S&P BSE HEALTHCARE
1-Day 1.03% -3.94% 0.11%
1-Month 12.57% -16.47% -3.22%
1-Year 122.38% -33.17% 42.65%
3-Year CAGR 78.81% -9.55% 19.86%
5-Year CAGR 83.14% 6.04% 25.90%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the MEDICAMEN BI share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of MEDICAMEN BI the stake stands at 43.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of MEDICAMEN BI.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.6 per share. This amounted to a Dividend Payout ratio of 8.6%.

MEDICAMEN BI paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of MEDICAMEN BI.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.